Elaine F. Reed

Elaine F. Reed is a Professor-in-Residence in the Department of Pathology and Laboratory Medicine at the University of California, Los Angeles (UCLA), with a primary appointment in the David Geffen School of Medicine. Her extensive research focuses on transplant immunology, particularly the mechanisms of antibody-mediated rejection, HLA antibodies, and the immune response in organ transplant recipients. She serves as a key investigator in multiple national studies examining immune responses in transplantation and viral infections.

Dr. Reed's research interests span several critical areas in transplant immunology:

• Mechanisms of antibody-mediated rejection in solid organ transplantation
• Role of HLA and non-HLA antibodies in transplant outcomes
• Immune monitoring of transplant recipients
• Cytomegalovirus (CMV) immunity in transplant recipients
• Epigenetic regulation of immune responses post-transplantation
• Host immune responses to SARS-CoV-2 in immunocompromised patients
• Development of biomarkers for rejection and infection risk

Her recent publication record reveals a strong focus on cutting-edge research at the intersection of transplantation and immunology. Dr. Reed's work increasingly incorporates multi-omics approaches, including epigenetics, proteomics, and transcriptomics, to understand immune dysregulation in transplant recipients. A significant portion of her recent work examines the impact of SARS-CoV-2 on transplant patients, with particular attention to immune responses, long-term sequelae, and risk prediction models. Her research also continues to advance our understanding of CMV immunity, antibody-mediated rejection mechanisms, and the development of novel biomarkers for clinical use in transplantation.

Dr. Reed has been actively involved in mentoring numerous trainees and junior investigators in the field of transplant immunology. Her laboratory serves as a hub for collaborative research, working closely with clinicians and scientists across multiple institutions. She has secured substantial funding for her research, including NIH T32 training grants and other research support focused on understanding immune responses in transplantation.

Dr. Reed leads or co-leads several research initiatives, including the CMV Systems Immunobiology Group and participation in the IMPACC (Immunophenotyping Assessment in a COVID-19 Cohort) Consortium. Her laboratory employs advanced techniques in flow cytometry, epigenetic analysis, and multi-omics to investigate immune responses in transplant recipients. The team works closely with clinical transplant programs at UCLA to translate basic science findings into clinical applications for improving transplant outcomes.